FLUOROURACIL | A209219 | INGENUS PHARMACEUTICALS LLC
No patent or exclusivity listings for this strength.
INGENUS PHARMS LLC assumed applicant responsibility for fluorouracil (NDA 209219, oral solution) from NOVAST LABS.
Old: NOVAST LABS
New: INGENUS PHARMS LLC
Ingenus Pharms LLC became the applicant for Fluorouracil NDA 209219, replacing Novast Labs.
Old: NOVAST LABS
New: INGENUS PHARMS LLC
Ingenus Pharmaceuticals LLC replaced Novast Laboratories Ltd as the applicant for Fluorouracil NDA 209219, Supplement 002.
Old: NOVAST LABORATORIES LTD
New: INGENUS PHARMACEUTICALS LLC
INGENUS PHARMACEUTICALS LLC acquired NDA 209219 for fluorouracil from NOVAST LABORATORIES LTD.
Old: NOVAST LABORATORIES LTD
New: INGENUS PHARMACEUTICALS LLC